DK1556045T3 - 4-aminopiperidinderivater, fremgangsmåder til fremstilling deraf og anvendelse deraf som medikamenter - Google Patents
4-aminopiperidinderivater, fremgangsmåder til fremstilling deraf og anvendelse deraf som medikamenterInfo
- Publication number
- DK1556045T3 DK1556045T3 DK03750658T DK03750658T DK1556045T3 DK 1556045 T3 DK1556045 T3 DK 1556045T3 DK 03750658 T DK03750658 T DK 03750658T DK 03750658 T DK03750658 T DK 03750658T DK 1556045 T3 DK1556045 T3 DK 1556045T3
- Authority
- DK
- Denmark
- Prior art keywords
- processes
- preparation
- medicaments
- aminopiperidine derivatives
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- BCIIMDOZSUCSEN-UHFFFAOYSA-N piperidin-4-amine Chemical class NC1CCNCC1 BCIIMDOZSUCSEN-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02022191 | 2002-10-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1556045T3 true DK1556045T3 (da) | 2006-11-27 |
Family
ID=32049973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03750658T DK1556045T3 (da) | 2002-10-04 | 2003-09-30 | 4-aminopiperidinderivater, fremgangsmåder til fremstilling deraf og anvendelse deraf som medikamenter |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7488741B2 (fr) |
| EP (2) | EP1556045B1 (fr) |
| JP (1) | JP2006513151A (fr) |
| KR (1) | KR20050055748A (fr) |
| CN (1) | CN1688307A (fr) |
| AT (1) | ATE334680T1 (fr) |
| AU (1) | AU2003270291A1 (fr) |
| BR (1) | BR0314811A (fr) |
| CA (1) | CA2500664A1 (fr) |
| DE (1) | DE60307308T2 (fr) |
| DK (1) | DK1556045T3 (fr) |
| ES (1) | ES2268406T3 (fr) |
| MX (1) | MXPA05003290A (fr) |
| NO (1) | NO20052172L (fr) |
| NZ (1) | NZ539015A (fr) |
| PL (1) | PL376368A1 (fr) |
| PT (1) | PT1556045E (fr) |
| RU (1) | RU2005110409A (fr) |
| SI (1) | SI1556045T1 (fr) |
| WO (1) | WO2004030668A1 (fr) |
| ZA (1) | ZA200502330B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060079554A1 (en) * | 2002-12-06 | 2006-04-13 | Barry Peter C | Inhibitors of monomine uptake |
| ATE383335T1 (de) | 2003-06-11 | 2008-01-15 | Lilly Co Eli | 3-amino-pyrrolidine als inhibitoren der monoamin- wiederaufnahme |
| WO2005053663A2 (fr) * | 2003-11-24 | 2005-06-16 | Eli Lilly And Company | Traitement de la defaillance cognitive |
| US7615648B2 (en) * | 2004-06-01 | 2009-11-10 | Eli Lilly And Company | Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake |
| ES2864862T3 (es) | 2013-03-12 | 2021-10-14 | Celltaxis Llc | Métodos de inhibición de la leucotrieno A4 hidrolasa |
| MX2015011677A (es) | 2013-03-14 | 2016-07-08 | Celtaxsys Inc | Inhibidores de leucotrieno a4 hidrolasa. |
| WO2019232306A1 (fr) | 2018-05-31 | 2019-12-05 | Celtaxsys, Inc. | Procédé de réduction d'exacerbations pulmonaires chez des patients atteints d'une maladie respiratoire |
| CN111233751B (zh) * | 2020-03-25 | 2021-02-02 | 丽水绿氟科技有限公司 | 一种3,3-二氟-4-氨基哌啶类化合物及其衍生物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EG12406A (en) * | 1976-08-12 | 1979-03-31 | Janssen Pharmaceutica Nv | Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
| JPH05148234A (ja) * | 1991-10-02 | 1993-06-15 | Hokuriku Seiyaku Co Ltd | アルカン酸誘導体 |
| DE4404183A1 (de) * | 1994-02-10 | 1995-08-17 | Merck Patent Gmbh | 4-Amino-1-piperidylbenzoylguanidine |
| GB0108876D0 (en) * | 2001-04-09 | 2001-05-30 | Novartis Ag | Organic Compounds |
-
2003
- 2003-09-30 CN CNA03823730XA patent/CN1688307A/zh active Pending
- 2003-09-30 NZ NZ539015A patent/NZ539015A/en unknown
- 2003-09-30 ES ES03750658T patent/ES2268406T3/es not_active Expired - Lifetime
- 2003-09-30 KR KR1020057005877A patent/KR20050055748A/ko not_active Application Discontinuation
- 2003-09-30 BR BR0314811-4A patent/BR0314811A/pt not_active IP Right Cessation
- 2003-09-30 EP EP03750658A patent/EP1556045B1/fr not_active Expired - Lifetime
- 2003-09-30 PL PL03376368A patent/PL376368A1/xx not_active Application Discontinuation
- 2003-09-30 DE DE60307308T patent/DE60307308T2/de not_active Expired - Lifetime
- 2003-09-30 AU AU2003270291A patent/AU2003270291A1/en not_active Abandoned
- 2003-09-30 DK DK03750658T patent/DK1556045T3/da active
- 2003-09-30 WO PCT/EP2003/010824 patent/WO2004030668A1/fr active IP Right Grant
- 2003-09-30 AT AT03750658T patent/ATE334680T1/de not_active IP Right Cessation
- 2003-09-30 JP JP2004540745A patent/JP2006513151A/ja active Pending
- 2003-09-30 PT PT03750658T patent/PT1556045E/pt unknown
- 2003-09-30 SI SI200330506T patent/SI1556045T1/sl unknown
- 2003-09-30 RU RU2005110409/04A patent/RU2005110409A/ru not_active Application Discontinuation
- 2003-09-30 CA CA002500664A patent/CA2500664A1/fr not_active Abandoned
- 2003-09-30 EP EP06008607A patent/EP1693061A1/fr not_active Withdrawn
- 2003-09-30 US US10/528,924 patent/US7488741B2/en not_active Expired - Fee Related
- 2003-09-30 MX MXPA05003290A patent/MXPA05003290A/es not_active Application Discontinuation
-
2005
- 2005-03-18 ZA ZA200502330A patent/ZA200502330B/en unknown
- 2005-05-03 NO NO20052172A patent/NO20052172L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003270291A1 (en) | 2004-04-23 |
| DE60307308T2 (de) | 2006-12-28 |
| CA2500664A1 (fr) | 2004-04-15 |
| RU2005110409A (ru) | 2005-09-10 |
| DE60307308D1 (de) | 2006-09-14 |
| US7488741B2 (en) | 2009-02-10 |
| BR0314811A (pt) | 2005-08-02 |
| JP2006513151A (ja) | 2006-04-20 |
| NZ539015A (en) | 2006-02-24 |
| ZA200502330B (en) | 2006-05-31 |
| PL376368A1 (en) | 2005-12-27 |
| NO20052172D0 (no) | 2005-05-03 |
| EP1693061A1 (fr) | 2006-08-23 |
| EP1556045A1 (fr) | 2005-07-27 |
| KR20050055748A (ko) | 2005-06-13 |
| ES2268406T3 (es) | 2007-03-16 |
| MXPA05003290A (es) | 2005-07-05 |
| CN1688307A (zh) | 2005-10-26 |
| PT1556045E (pt) | 2006-12-29 |
| SI1556045T1 (sl) | 2007-02-28 |
| NO20052172L (no) | 2005-06-30 |
| WO2004030668A1 (fr) | 2004-04-15 |
| ATE334680T1 (de) | 2006-08-15 |
| EP1556045B1 (fr) | 2006-08-02 |
| US20060128753A1 (en) | 2006-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052172D0 (no) | 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter | |
| NO20051689L (no) | Substituerte piperaziner, (1,4) diaszepiner og 2,5-diazabicyklo(2.2.1) heptaner som histamin H1 og/eller H3 antagonister eller histamin H3 revers antagonister | |
| NO20055219L (no) | Nye forbindelser | |
| IL187438A0 (en) | Pyrrolopyridine derivatives and pharmaceutical compositions containing the same | |
| CL2003002683A1 (es) | Enantiomeros s de compuestos derivados del acido (2s)-3-4(-{2-amino-2-oxoetoxi}fenil)-2-etoxipropanoico; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento o prevencion de trastornos de lipidos, | |
| NO20062677L (no) | Benzyleteraminforbindelser anvendbare som CCR-5-antagonister | |
| SE0301009D0 (sv) | Novel compounds | |
| BR0307058A (pt) | N-óxidos de derivados de n-fenil-2-pirimidina-amina | |
| ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
| NO20051962L (no) | Fenetanolaminderivater for behandling av respiratoriske sykdommer | |
| EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
| EA200701296A1 (ru) | 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства | |
| NO20055092L (no) | Substituerte pyrimidioner | |
| NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
| TW200611695A (en) | Pyrrolopyridine derivatives | |
| ES2340502T3 (es) | Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad. | |
| NO20045486L (no) | Nye forbindelser og deres anvendelse | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| NO330888B1 (no) | Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom | |
| CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
| NO990433L (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
| SE0301446D0 (sv) | New Compounds | |
| EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
| AU2003260436A1 (en) | Pyrimidine compounds | |
| MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. |